A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma
Author:
Eiji Kiyohara et al
Publication:
Cancer Immunology, Immunotherapy
Publisher:
Springer Nature
Copyright © 2022, The Author(s)